Ionis Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Great. Good morning, everyone. Welcome. My name is Jess Fye, large-cap biotech analyst at JPMorgan, and we're continuing the 44th Annual Healthcare Conference this morning with Ionis. You're going to hear a presentation from the management team, and then we're going to go into some Q&A.
So if you have any questions in the room, just raise your hands, and someone will bring you a microphone or you can submit them online, and I can read them off the iPad up here.
So with that out of the way, let me pass it over to Ionis CEO, Brett Monia.
Thank you, Jess. Good morning, everybody. Thanks for joining me today for today's presentation. As Jess said, I'm Brett Monia, CEO of Ionis, now entering my seventh year as CEO of the company, and I couldn't be more thrilled to present to you the remarkable progress that we've made over the last couple of three years at Ionis, but more importantly, how the momentum we've built over the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
